Corporate venture capital in 2026: record dollars, thinner deal flow, almost all of it AI

For two years the steadiest part of the venture market has not been financial funds but corporate balance sheets. Global Corporate Venturing recorded corporate venturing at a record high in 2025, with more than 3,000 companies actively investing in startups even as the rest of the venture industry declined. Roughly one in five funding rounds now includes a corporate backer.

But the headline masks a very narrow structure. PitchBook's Q3 2026 analyst note finds corporate investors now account for a record 87.9% of US AI venture deal value in 2026, even as they participate in a smaller share of deals overall and the CVC population contracts from its 2021 peak. AI accounts for more than 90% of all corporate VC deal value.

Record money, slowing deal rhythm

KPMG's Venture Pulse puts global CVC investment at $149.1bn in Q2 2026 alone, on a record pace, with total global venture funding reaching $560.4bn at mid-year, a five-year high. Global Corporate Venturing calculates that funding into corporate-backed rounds jumped 231% year on year in Q2 2026, driven by AI mega-rounds, making it the second-highest quarter on record.

SVB's State of Corporate Venture Capital 2026, co-authored with Counterpart Ventures and drawing on nearly 200 of the largest CVC funds and more than 1,400 investments, describes the same paradox: record capital deployment alongside slowing deal activity. More money is passing through fewer doors.

Corporates are not just investing directly — they are becoming fund LPs

A quieter shift: according to Global Corporate Venturing analysis published in July 2026, more than half of venture funds that closed in the second quarter included commitments from corporate investors, with much of that capital going to first-, second- and third-time managers. Corporates now run three tools in parallel: CVC units, direct balance-sheet investment, and LP commitments into funds.

For new managers this is the most realistic pool available. KPMG recorded global VC fundraising of $98.8bn by the end of Q2 2026 across just 727 funds, against 1,744 funds for all of 2025 — fund counts remain depressed even if the dollar total surpasses 2025's decade-low $145.9bn. With traditional institutional LPs cautious, corporate money is the door still open.

The cost sits in the terms, not the valuation

Corporate investors often accept higher valuations because they are buying strategic position, not only financial return. In exchange they tend to ask for terms that can lock a company's future: rights of first refusal, notification rights on any sale, distribution exclusivity, or access to product data. For an early angel investor, these clauses decide whether the position ever has an exit.

The exit backdrop raises the stakes: SVB found the share of M&A deals with a VC-backed buyer climbed to 46% in 2025, while sale-price-to-capital-raised multiples compressed and strategic buyers grew more price-sensitive. If the likely acquirer is also the shareholder holding pre-emption rights, the founder's negotiating room narrows sharply.

• Cap rights of first refusal with a defined term; avoid open-ended pre-emption over any sale of the company.
• Do not sign commercial exclusivity tied to the investment; keep commercial contracts separate from the share purchase.
• Limit data and competitive-information access when the investor is also a customer or a potential rival.
• Keep at least one independent financial investor in the round to balance interests when exit talks begin.
• Specify what happens if the corporate investor restructures or shuts its CVC unit.

Concentration risk matters too: corporate capital is clustering in a very small group of leading AI companies. SVB data shows that of $560bn invested in AI globally across roughly 24,700 companies, one-third went to five companies, and the five largest AI companies alone raised $192bn. The rest of the market still competes under ordinary conditions.